Rare diseases
Investigational molecules
Locations
Back to Hungary90 clinical trials in Miskolc, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on Lutikizumab and Risankizumab for Adults with Active Psoriatic Arthritis
HungaryStudy of PF-06821497 and Enzalutamide for Men with Advanced Prostate Cancer Resistant to Hormone Therapy
HungaryStudy on Pegaspargase and Rituximab for Treating Children with Acute Lymphoblastic Leukemia
HungaryStudy on Long-term Safety of Vedolizumab and Prednisone in Children with Ulcerative Colitis or Crohn's Disease
HungaryStudy Comparing Inotuzumab Ozogamicin to Drug Combination for Children with High-Risk Relapsed B-cell Acute Lymphoblastic Leukemia
HungaryStudy on the Effectiveness and Safety of Vedolizumab, Budesonide, and Prednisone for Children with Moderate to Severe Crohn's Disease
HungaryStudy on the Effectiveness and Safety of Saruparib and Camizestrant in Adults with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
HungaryStudy on Long-Term Safety of KarXT (Trospium Chloride, Xanomeline Tartrate) for Patients with Alzheimer's-Related Psychosis
HungaryStudy on the Effectiveness and Safety of KarXT for Treating Psychosis in Patients with Alzheimer's Disease
HungaryStudy of AZD5305 with Abiraterone Acetate and Darolutamide in Men with Metastatic Castration-Sensitive Prostate Cancer
HungaryStudy Comparing MK-5684 with Abiraterone Acetate or Enzalutamide for Patients with Advanced Prostate Cancer After Hormonal Therapy
HungaryStudy on Lymphoblastic Lymphoma Treatment in Children and Adolescents Using Dexamethasone, Prednisone, and PEG-Asparaginase
HungaryThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on breast cancer treatments, including studies for both triple-negative and ER+/HER2- variants. Research includes evaluation of new therapeutic combinations and prostate cancer treatments.
Studies emphasize novel treatment approaches and combination therapies for improving patient outcomes.
Comprehensive research into cardiovascular diseases and preventive treatments, including studies on stroke prevention and atherosclerosis management.
Trials evaluate new medications for reducing cardiovascular events and improving patient outcomes.
Investigations into treatments for inflammatory conditions and autoimmune disorders, with particular focus on dermatological and gastrointestinal diseases.
Research aims to develop targeted therapies for chronic inflammatory conditions.
Studies focusing on children's health, including respiratory infections, vaccine development, and treatment of childhood diseases.
Emphasis on developing safe and effective treatments for young patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
